Oral lymphatic delivery of alpha-galactosylceramide and ovalbumin evokes anti-cancer immunization-Reference-Cited by-同舟云学术

Oral lymphatic delivery of alpha-galactosylceramide and ovalbumin evokes anti-cancer immunization

Published:2023-04 Issue: Volume:356 Page:507-524
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Pandey Prashant,Kim Seung Hyun,Subedi Laxman,Mujahid Khizra,Kim Yebon,Cho Young-Chang,Shim Jung-Hyun,Kim Ki-Taek,Cho Seung-Sik,Choi Jeong Uk,Park Jin Woo

Funder

National Research Foundation of Korea

Mokpo National University

Ministry of Science, ICT and Future Planning

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference50 articles.

1. Five-year survival with combined Nivolumab and Ipilimumab in advanced melanoma;Larkin;N. Engl. J. Med.,2019

2. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N. Engl. J. Med.,2012

3. The foundations of immune checkpoint blockade and the ipilimumab approval decennial;Korman;Nat. Rev. Drug Discov.,2022

4. Vaccines combined with immune checkpoint antibodies promote cytotoxic T-cell activity and tumor eradication;Ali;Cancer Immunol. Res.,2016

5. Liposomal nanovaccine containing α-galactosylceramide and ganglioside GM3 stimulates robust CD8(+) T Cell responses via CD169(+) macrophages and cDC1;Grabowska;Vaccines (Basel),2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-coated gold nanorods for photoimmunotherapy of primary breast cancer and the prevention of metastasis;Journal of Controlled Release;2024-09

2. mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends;Biomarker Research;2024-08-31

3. Oral targeted drug delivery to post-gastrointestinal sites;Journal of Controlled Release;2024-06